[Skip to Content]
[Skip to Content Landing]
Article
December 18, 1967

WASHINGTON NEWS

JAMA. 1967;202(12):39-40. doi:10.1001/jama.1967.03130250025004

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

The Senate-passed "generic" drug provision would prove "highly detrimental to the health of the American people," the Pharmaceutical Manufacturers Association said.

C. Joseph Stetler, PMA president, said that the amendment "would have drastic, far-reaching effects on our medical system and would relegate a large segment of the population to 'second-class citizenship' insofar as their medical care is concerned."

Stetler said that the drug system proposed in the legislation would greatly increase government procurement costs as a result of additional checks, tests, inspections, and scientific reviews which would be required.

"This would clearly result in unnecessary, increased administrative expense for the American public," he said, adding that dispensing prescriptions written in generic terms "would not necessarily result in lower prices."

The amendment, part of the overall social security-medicare bill before a House-Senate conference committee, calls for the creation of a "formulary of the United States" which would list specific drugs to

×